Skip to main content
. 2020 Jun 24;177(16):3778–3794. doi: 10.1111/bph.15100

FIGURE 4.

FIGURE 4

Anti‐arrhythmic properties of XAF‐1407: (a) cardioversion success rate (%) of horses in self‐sustained AF with XAF‐1407 treatment over time. (b) Assessment of anti‐arrhythmic properties of XAF‐1407 versus vehicle (NaOAc) on day 11. * P < .05, significantly different as indicated